
    
      This is a limited prospective collection of whole blood samples from pregnant women with a
      diagnosis of preterm preeclampsia and/or fetal growth restriction in addition to samples from
      a control group to aid in the development of a Next Generation Sequencing (NGS)-based assay
      to detect molecular markers associated with preterm preeclampsia.
    
  